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Abstract
Mast cells are secretory cells responsible for fighting off infection through the early
recognition of pathogens. This process is completed through the secretion of proinflammatory
mediators that are stored in secretory granules within the cytoplasm of the cell. The degranulation
secretion process relies on regulated fusion of secretory granules to the cell membrane via
membrane-bound SNARE proteins that bridges the two opposed membranes. The
intricate regulation of SNARE-mediated mast cell degranulation is not well understood. However,
Sec1/Munc18 (SM) proteins, specifically the Munc18 isoforms, are known to play a critical role
in the process (Brochetta, et. al., 2014). The Xu lab has recently demonstrated that Munc18a is
phosphorylated in activated RBL-2H3 cells (a tumor analog of mucosal mast cells), and current
research seeks to determine the function and physiological relevance of Munc18a phosphorylation.
To achieve this, we are in the process of generating Munc18a-specific antibodies that would be
used to specifically isolate Munc18a from resting and activated RBL-2H3 cell. Munc18a proteins
will then be subject to mass spectrometry to identify novel phosphorylation sites. This project
seeks to generate an epitope of Munc18a that will be used in this specific antibody production.
This is being carried out by the amplification and isolation of a segment of the gene encoding
Munc18a, subcloning it into bacterial expression vector pMBP-parallel, and expressing it in E. coli
bacterium. In collaboration with others in the Xu lab, the isolated Munc18a cDNA will be used to
raise antibodies with high specificity and sensitivity for Munc18a. I expect my research product to
be essential for generating fresh new insights into the importance of Munc18a phosphorylation in
mast cell degranulation.
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Chapter 1: Introduction
Mast cells are secretory cells found in connective tissues (e.g., respiratory tract,
intestines and stomach lining) and are responsible for fighting off infection through the
early recognition of pathogens. Mast cells accomplish this by secreting inflammatory
mediators, such as histamine and proteases, which are stored in secretory granules within
the cytoplasm of the cell. The secretion of these mediators, referred to as mast
cell degranulation, could lead to allergic inflammation and anaphylaxis when misregulated. Degranulation relies on regulated fusion of secretory granules to the
cell membrane (Lorentz et al, 2012). It is important to study how the degranulation
process is regulated, because if the regulation process can be controlled, further studies
can be done to positively affect the immune system. Membrane fusion, the conserved
process by which mast cell degranulation can take place, is essential to intercellular
trafficking. Membrane fusion begins as the transport vesicle approaches the target
membrane, allowing for a hemi fusion of the outer lipid bilayers of each respective
membrane (Figure 1). The fusion between vesicle and target membranes is catalyzed by
specific proteins and lipids. Soluble N-ethylmaleimide-sensitive factor attachment protein
receptor (SNARE) are integral or peripheral proteins crucial to membrane fusion by
forming a trans-complex that impose stress to the lipid bilayers (Figure 2).

1

Figure 1: (A)The vesicle approaches the target membrane. (B) The outer regions of the
lipid bilayer form a hemi-fusion attachment. (C) The inner bilayers combine, showing
full fusion to take place. This allows for the translocation of secretory granules.

The SNARE complex that bridges two apposed membranes is formed by four
helixes: three t-SNAREs and one v-SNARE coiled together (Alpadi et al, 2012). This
family of SNARE proteins is made up of syntaxin, synaptobrevin/VAMP (vesicle
associated membrane protein), and SNAP 25-like protein. VAMPs are found on the
transport vesicle membrane and are classified as v-SNAREs. Syntaxin and SNAP 25-like
proteins are found on the target cell membrane, and they are classified as t-SNAREs.
Fusion of the vesicle and target lipid membranes relies on the formation of the transSNARE complex, made up of these SNARE proteins (Peijler and Wernersson, 2014).
Although SNARE- mediated fusion has been the center of many research experiments,
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the regulation of their assembly and disassembly is still unclear (Jorgensen and
Palfreyman, 2008). However, we do know that interactions between different regulatory
proteins and the SNARE complexes take part in the steps to regulate mast cell granule
fusion. Three cytoplasmic proteins that interact with the SNARE complex, Munc18a,
Munc18b, and Munc18c, make up the mammalian uncoordinated18 (Munc18) family
(Lorentz et al, 2012). The Munc18 proteins bind to the SNARE proteins and are thought
to be required for all regulated exocytosis (e.g., neurotransmission, hormone secretion
and mast cell degranulation).

Figure 2: Membrane fusion via SNAREs. (A) shows the interaction between VAMP-2,
syntaxin-1a, and SNAP 25 once the vesicle has moved close enough to the target
membrane. (B) shows the formation of the trans-SNARE complex as the protein helices
coil together, strengthening the bond. (C) shows the fully assembled SNARE complex.
This allows for hemi fusion of the two membranes to begin, followed by full fusion
(Jorgensen and Palfreyman, 2008).
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Of the three Munc18 isoforms, recent studies have shown that Munc18a plays a
role in both mast cell degranulation as well as neurotransmitter release in neuronal cells
(Dulubova et. al., 2007). Munc18a has many roles in the regulation of SNARE-mediated
membrane fusion. Munc18a’s role in mast cell degranulation and neurotransmitter release
relies on its interaction with SNARE proteins, syntaxin-1 and synaptobrevin. The Cterminus of synaptobrevin has a Munc18a binding site, allowing it to interact with the
SNARE protein near the site of membrane fusion. The Munc18a protein also interacts
with the N-terminus of syntaxin-1 to aid in facilitation of SNARE-mediated fusion by
inducing lipid mixing (Xu et. al., 2010). The N-pocket of the D1 domain of Munc18a is
what allows it to interact with the N-peptide of syntaxin-1 (Arnold et. al., 2017). Recent
studies show that post-translational modification of Munc18a could play a role in how it
can interact with these SNAREs to facilitate membrane fusion. For example, the
phosphorylation of Munc18a at Ser-313 by Protein Kinase C is related to controlling
exocytosis (Barclay et. al., 2003). Despite everything that we already know about the
roles that Munc18a plays SNARE-mediated membrane fusion, there is still much to be
learned about how exactly the Munc18a isoform specifically interacts with the different
combinations of SNAREs that make up the trans-SNARE complex. We wanted to create
the Munc18a epitope for antibody production so that we could obtain an endogenous
Munc18a protein sample. Creating our own Munc18a-specific antibody instead of using a
commercial antibody will ensure that only the Munc18a isoform binds to it, as well as
cutting down on the expense of purchasing a specific antibody.
The goal for this research was to produce a successful gene construct for an
epitope of Munc18a near the C-terminus that can be used in Munc18a- specific antibody
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production for immunoprecipitation studies. The C-terminus was chosen as the site for
our epitope because this area shows the most variation among the three Munc18
isoforms. While producing this gene construct for Munc18a is the first step in being able
to produce Munc18a- specific antibodies, it is an extremely important step because it
provides a base for which future studies in the Xu lab will build upon. This allows the
antibody that will later be produced using our Munc18a protein a higher specificity.
Production of this antibody will be completed by others in the Xu lab by injecting the
Munc18a peptide into New Zealand White rabbits and allowing it to illicit an immune
response (Figure 3). The rabbit’s B-cells will produce antibodies against the peptide, that
will serve as the antigen. The serum will then be harvested from the rabbit and affinity
purified (“Practical Applications of Monoclonal and Polyclonal Antibodies”).

Figure 3: Antibody production process in rabbits.
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The purified antibody will allow the Xu lab to isolate the endogenous Munc18a
protein produced by RBL-2H3 cells through immunoprecipitation to be analyzed in
future mast cell degranulation reactions (“Practical Applications of Monoclonal and
Polyclonal Antibodies”). Immunoprecipitation will be performed in future studies using
the obtained antibody for the desired Munc18a epitope near the C-terminus. The antibody
pre-immobilized onto beads will bind with Munc18a from RBL-2H3 cell lysates in both
resting and activated states. During incubation, the cell lysate will agitate and allow for
the binding of the antibody and Munc18a, forming an immune complex. The complex
will then be collected and separated from the beads for further analysis of the target
antigen, Munc18a.
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Figure 4: Immunoprecipitation will be performed using the obtained antibody for the
desired Munc18a epitope near the C-terminus. The Munc18a will serve as the antigen and
bind to the previously obtained antibody.

Chapter 2: Materials and Methods
Polymerase Chain Reaction
The first step in this process was to design and obtain primers for the Munc18a
epitope sequence and amplify the cDNA by performing PCR. To begin PCR, 1uL
(100ng/uL) of the plasmid DNA obtained for the Munc18a, 40uL of Millipore water, 1uL
of 10 uM NcoI primer, 1uL of 10uM EcoRI primer, 5uL of 10x Pfu buffer, 1uL of 10mM
dNTPs (New England Biolabs), and 1uL Pfu polymerase (G Biosciences part #) was
placed in a PCR tube. PCR was then run according to the following times and
temperatures to amplify the nucleic acids: 94°C/5min (1 cycle), 94°C/30s, 55°C/30s,
72°C/45s (5 cycles), 94°C/30s, 60°C/30s, 72°C/45s (25 cycles), 72°C/10min (1 cycle)
then 4°C/∞. After completing PCR, the PCR product was analyzed by electrophoresis
using 1% agarose gel. 10uL of each product was mixed with 2uL of gel red fluorescent
dye to visualize the DNA and placed in its assigned compartment. It was run next to 6uL
of 1kB DNA ladder with 2uL of gel red added for a total of 8uL. The remaining 40uL of
each product was placed in the -20°C freezer for later use in the lab. The gel was set
under UV light and a picture of the results was taken and saved in the computer files.
After completing purification, Nano drop readings were taken to observe the
concentration of the DNA (ng/uL) present. The pMBP-parallel vector was isolated
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using a QIAprep Spin Miniprep kit per respective protocol before restriction and
digestion began.

Restriction Digestion/Ligation
To begin restriction digestion, we mixed the 29uL of PCR products (Munc18a
epitope) with 15uL of sterile millipore water. This was followed by adding 5uL of 10x
NEB CutSmart buffer (Biolabs), and 0.5uL of each restriction enzyme, NcoI and EcoRI
(Biolabs). This process was repeated with 40 uL of vector pMBP-parallel DNA, except
without the H2O. The mixtures were incubated at 37C for 3 hours. Next, the vector was
inactivated by incubating at 65C for 20 minutes, then placed on ice for 2 minutes. 1uL
of alkaline phosphatase, used to dephosphorylate the 5’ and 3’ ends of the DNA, was
added to the vector only sequence and incubated at 37C for 1 hour. The vector was then
heat inactivated at 65C for 20 minutes. This process allowed the vector plasmid, pMBPparallel, to open and create sticky ends on both the vector and the Munc18a epitope in
preparation for the recombination of the DNA (Figure 5).
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Figure 5: This figure shows where restriction enzymes, EcoRI and NcoI cut vector,
pMBP-parallel, to allow for ligation of the insert. These restriction enzymes were chosen
because they cut the vector once and do not cut the insert. NcoI and EcoRI cut 11bp from
the pMBP-parallel vector. The ampicillin resistance was selected to ensure that,
following restriction digestion, no contaminates survived the transformation step.

Following restriction digestion of both the insert and the vector, both restriction
digestion products were run on a 0.7% agarose gel at 80V for 1 hour using gel red to
fluoresce. The vector was run next to a 6 DNA ladder. The insert was run next to a 1kB
DNA ladder. A gel extraction of the restriction digestion products was performed next
using the QIAprep Gel Extraction Kit protocol. The restriction digestion vector product
was 0.26g and the insert product was 0.169g. To begin ligation, ligation buffer, T4 DNA
ligase, insert DNA, and vector DNA was added to labeled microcentrifuge tubes (Table
1). The tubes were incubated overnight at 17C. This allowed for the Munc18a cDNA to
attach to the selected vector plasmid at the sticky ends.
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Table 1- Ligation protocol.
Munc18a (insert) +

pMBP-parallel (vector/

pMBP-parallel (vector)

control)

T4 Ligase

1uL

1uL

10x Buffer

1uL

1uL

pMBP-parallel vector

3uL

3uL

Munc18a insert

5uL

0uL

Millipore water

0uL

5uL

Transformation of Novablue
Once the ligation of the Munc18a with the pMBP-parallel vector was complete,
the next step was to transform competent E. coli to select for the engineered construct
(vector plus insert). To begin this process, the competent cells were thawed on ice. The
cells were put into chilled 1.5ml micro-centrifuge tubes taken in 15uL increments. 1.5uL
of each ligation product was mixed with the 15uL cells in tubes by flicking the tube.
After the tubes are completely mixed, they were placed on ice for 30 minutes, then heat
shocked for 45 seconds at 42°C in a heating block, then put back in the ice immediately
for 10 more minutes. 75uL of S0C media was added to each tube and incubated at 37°C
for 1 hour. After the 1-hour incubation was complete, each mixture was transferred to
LB/Ampicillin (100ug/mL) agar plates with 5-7 sterile glass beads. To spread the cells
out evenly on the plates, the plates were rotated horizontally on the bench for 15 seconds.
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Once the glass beads were removed, the plates were placed in the incubator for 20
minutes, then inverted overnight at 37°C.

Plasmid Isolation/Sequencing
Within the next year, further studies will be conducted in the Xu lab to attempt to
confirm the Munc18a sequence through sequencing of the plasmids grown during
transformation. Colonies grown on the plates overnight will be inoculated and isolated
before being sent off for sequencing. Upon receiving the sequencing results, a nucleotide
BLAST will be run on the NCBI website of our sequence results with the predicted
sequence of our Munc18a. From this BLAST, the two sequences can be compared to
determine if any error occurred or if the presence of Munc18a is confirmed.

Chapter 3: Results and Discussion
Munc18a rat cDNA was used to amplify an epitope near the C-terminus using
PCR. PCR amplification was performed using custom primers. A 561bp construct was
created using a forward and a reverse primer (Figure 6).
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Figure 6: A nucleotide BLAST was performed showing the alignment between the
Munc18a epitope sequence and the custom designed forward primer which includes an
EcoRI restriction site. The nucleotides indicated by the red box depict epitope sequence
of Munc18a. The green box depicts an additional cytosine that was added to the primer
sequence to keep the sequence in reading frame after cloning into the expression vector.
The orange box depicts where the restriction site begins.

Gel electrophoresis of the PCR product was carried out using 1.0 % agarose gel.
A 1Kb DNA ladder was used to measure the size of the fragments present. 18x gel red
was used to fluoresce samples. The epitope sequence of Munc18a near the C-terminus
was successfully amplified using PCR (Figure 7). The PCR product was visually
confirmed using the band located at the 0.6kB mark compared to the 1kB DNA ladder
run next to it. The desired Munc18a epitope sequence is 561 bp, so a band was expected
right above the 0.6kB mark where the arrow is indicating our sample was.
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Figure 7: This figure shows a 1kB ladder in the left lane and PCR products in the right
lane. The gel confirms that the desired 0.6kB insert was amplified using PCR, as
indicated by the arrow.

Following PCR amplification, the PCR product was digested along with the
pMBP-parallel vector using EcoRI and NcoI restriction enzymes. The restriction
enzymes were used to cut 11bp from the vector and create sticky ends to prevent the
plasmid from self-ligating. These cuts in the vector allowed for the Munc18a epitope
sequence to be inserted into the vector. Restriction enzymes EcoRI (BioLabs Cat#
0331205) and NcoI (BioLabs Cat#0301209) were selected as both enzymes cut the vector
plasmid once while not cutting the Munc18a cDNA. EcoRI was also chosen for its
maintenance of reading frame. Restriction digestion was performed on partial Munc18a
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cDNA (Figure 8) as well as the vector plasmid (Figure 9). Gel electrophoresis was
performed using 0.7% agarose, followed by gel extraction of all products.

Figure 8: Restriction digestion of insert, Munc18a, was performed and run next to a 1kB
DNA ladder. The insert is in the left lane, and indicated with the arrow 0.6kB. The right
lane shows a 1kB ladder. This image can be compared to Figure 4 showing the
undigested insert to confirm the presence of Munc18a.

14

Figure 9: Restriction digestion of pMBP-parallel was performed and run next to a 6λ
DNA ladder. Lane (1) shows the undigested vector and lane (2) shows the restriction
digested vector. The 6λ DNA ladder was run in the far-right lane. The gel shows that the
digested and undigested vector are present at around 6kb.

A Nano-drop reading was taken after a gel extraction of the restriction digestion
products (Table 2) (Table 3). Approximately 1.8nm is a pure Nano-drop reading for
260/280 ratio, and approximately 2.0nm is pure for a 260/230 ratio. The restriction
digestion of the PCR products has a 0.95nm Nano-drop reading for the 260/280 ratio, and
a 0.01nm reading for the 260/230 ratio (Table 2). These lower Nano-drop readings
indicate that contamination of a protein, phenol, or other reagent used in the DNA
extraction is present. The restriction digestion of the vector has a 2.24nm reading for the
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260/280 ratio, and 0.02nm reading for the 260/230 ratio (Table 3). The high 260/280 ratio
for the pMBP-parallel vector could indicate that there is an RNA contamination.

ng/uL
Munc18a

260/280

20

1.14

260/230
1.63

Table 2- Nano-drop readings after PCR purification. The 260/280 and 260/230 ratios
show that there is a slight contamination. This could have occurred during preparation of
the PCR mixture or during the purification of the PCR products.

ng/uL

260/280

260/230

Munc18a

2.4

0.95

0.01

pMBP-parallel

10.4

2.24

0.02

Table 3- Nano-drop reading after gel extraction. The 260/280 and 260/230 ratios show
that there is a possible protein, contamination, or organic compound contamination. This
could have occurred the restriction digestion process or the gel extraction.

Following restriction digestion, ligation of the vector and insert was performed
(Table 1). The recombinant plasmid containing the pMBP-parallel vector and Munc18a
epitope sequence were then transformed into E. coli expression strain, Novablue. (Figure
10). This allowed for the plasmid to be transformed into the Novablue E. coli strain for
expression. The plate on the left contains both the vector and insert. The plate on the right
served as a control and contains only the vector mixed with millipore water (Figure 10).
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We observed that 11 colonies grew on the ampicillin resistant growth medium on Plate 1.
Plate 2, the control, showed no colony growth. Successful ligation of the vector and insert
was confirmed by the colony growth on Plate 1 (Figure 10). Ligation of the vector and
insert allowed colonies to grow because of the plasmid’s selected marker for ampicillin
resistance. Plate 2, showing no colony growth, confirmed that there was no presence of
the Munc18a insert added. Although the pMBP-parallel vector itself contains an
ampicillin resistance, without the insert added, the plasmid cannot be transformed.

2

1

Figure 10: (1) Plate contains Munc18a epitope (insert) and pMBP-parallel (vector).
Successful ligation and transformation into Novablue competent cells was confirmed by
the growth of colonies (2) Plate only contains pMBP-parallel and millipore water to serve
as a control. No colonies are seen.
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Future studies conducted in the Xu lab will involve re-isolating the plasmids from
competent Novablue cells and sending them to be sequenced through Eurofins. The
sequencing results will be able to confirm the presence of Munc18a. Once the Munc18a
sequence is confirmed, the cloning product will be sent for use in antibody production,
followed by immunoprecipitation to obtain an endogenous protein. The endogenous
Munc18a protein will allow us to further study the role that Munc18a plays in SNAREmediated membrane fusion.
Although Munc18a is not the only protein that aids in SNARE-mediated fusion,
this research is extremely important because the more we understand about how the
SNARE-mediated fusion process is controlled, the more influence we have over
manipulating when it occurs. Being able to control SNARE-mediated fusion and in turn,
mast cell degranulation, could impact how physicians can treat allergies. As of now,
physicians are only able to treat allergies with limited success. According to the
American College of Allergy, Asthma, and Immunology (2016), over 50 million
Americans are still affected by allergies, and allergic disease is the sixth leading chronic
disease in the U.S. Being able to control the fusion process in mast cells can lead to better
treatment options for allergies and possibly prevention altogether. This not only can
positively improve a patient’s quality of life, but it can also ease the financial burden of
allergy treatment. In one year alone, the cost of allergy treatment in America is
approximately 18 billion dollars (American College of Allergy, Asthma, and Immunology,
2016).
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